The same study also confirmed downregulation of PRSS8 after silencing ZNF217 expression indicating the significance of ZNF217 as a key regulator [93] and suggesting PRSS8 as a potential biomarker in ovarian carcinomas. The gene discussed is PRSS8; the disease is ovarian carcinoma.